Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro

Anti-Inflammatory Action of Donepezil Ameliorates Tau Pathology, Synaptic Loss, and Neurodegeneration in a Tauopathy Mouse Model

(2017) Yasumasa Yoshiyama et al.   JOURNAL OF ALZHEIMERS DISEASE

ICAM-1 targeted catalase encapsulated PLGA-b-PEG nanoparticles against vascular oxidative stress

(2015) Ece Sari et al.   JOURNAL OF MICROENCAPSULATION

Interaction of selegiline-loaded PLGA-b-PEG nanoparticles with beta-amyloid fibrils

(2013) Ipek Baysal et al.   JOURNAL OF NEURAL TRANSMISSION

PEGylated Nanoparticles Bind to and Alter Amyloid-Beta Peptide Conformation: Toward Engineering of Functional Nanomedicines for Alzheimer’s Disease

(2012) Davide Brambilla et al.   ACS Nano

Microfluidics-Nano-Integration for Synthesis and Sensing

(2012) Simona Badilescu et al.   Polymers

Polymer therapeutics as nanomedicines: new perspectives

(2011) Ruth Duncan   CURRENT OPINION IN BIOTECHNOLOGY

Current and Emerging Drug Treatment Options for Alzheimerʼs Disease

(2011) Nathan Herrmann et al.   DRUGS

In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies

(2011) Pooja Naik et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Survival in Alzheimer disease: A multiethnic, population-based study of incident cases

(2008) E. P. Helzner et al.   NEUROLOGY

Nanoparticles: pharmacological and toxicological significance

(2007) C Medina et al.   BRITISH JOURNAL OF PHARMACOLOGY